BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28899360)

  • 1. Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease.
    Chatterjee P; Roy D; Bhattacharyya M; Bandyopadhyay S
    BMC Genomics; 2017 Sep; 18(1):721. PubMed ID: 28899360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
    Su L; Wang C; Zheng C; Wei H; Song X
    BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of Gene Expression and Identification of Biological Regulatory Mechanisms in Alzheimer's Disease.
    Su L; Chen S; Zheng C; Wei H; Song X
    Front Neurosci; 2019; 13():633. PubMed ID: 31333395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease.
    Zhang X; Feng S; Fan Y; Luo Y; Jin L; Li S
    Front Neurol; 2020; 11():810. PubMed ID: 32849243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.
    Odumpatta R; Arumugam M
    J Mol Neurosci; 2021 Mar; 71(3):466-480. PubMed ID: 32728898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying the system-level involvement of microRNAs in Parkinson's disease.
    Chatterjee P; Bhattacharyya M; Bandyopadhyay S; Roy D
    PLoS One; 2014; 9(4):e93751. PubMed ID: 24690883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
    Bao J; Chang W; Zhao Y
    J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel key lncRNAs involved in periodontitis by weighted gene co-expression network analysis.
    Jin SH; Zhou RH; Guan XY; Zhou JG; Liu JG
    J Periodontal Res; 2020 Jan; 55(1):96-106. PubMed ID: 31512745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of lncRNA/circRNA-miRNA-mRNA in the proliferative phase of liver regeneration in mice with liver fibrosis.
    Wang Q; Long Z; Zhu F; Li H; Xiang Z; Liang H; Wu Y; Dai X; Zhu Z
    BMC Genomics; 2023 Jul; 24(1):417. PubMed ID: 37488484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.
    Yan H; Wang Q; Shen Q; Li Z; Tian J; Jiang Q; Gao L
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S622-S627. PubMed ID: 30249878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson's Disease via Bioinformatics Analysis.
    Zhou Y; Li Z; Chi C; Li C; Yang M; Liu B
    Parkinsons Dis; 2023; 2023():6755569. PubMed ID: 37089789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease.
    Li J; Sun Y; Chen J
    Genes Genet Syst; 2019 Apr; 94(2):61-69. PubMed ID: 30713215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of long noncoding RNA-associated competing endogenous RNA network in periodontitis.
    Li S; Liu X; Li H; Pan H; Acharya A; Deng Y; Yu Y; Haak R; Schmidt J; Schmalz G; Ziebolz D
    J Periodontal Res; 2018 Aug; 53(4):495-505. PubMed ID: 29516510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
    Zhang J; Liu L; Li J; Le TD
    Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis.
    Wang T; Xu S; Zhang H; Lu X; Li S; Liu L; Kong X; Gao H; Wang X; Ning S; Wang J; Wang L
    Sci Rep; 2021 Dec; 11(1):23920. PubMed ID: 34907261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.